Briefing
Newly discovered CRISPR enzymes could lead to low cost, simultaneous disease diagnostics for multiple diseases, such as cancer and Zika virus
May 25, 2017
Briefing |
|
Accelerator |
|
Sector |
Healthcare/Health Sciences
|
Organization |
University of California - Berkeley
|
Source |
|
Original Publication Date |
May 4, 2017
|